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ARTICLE
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Chris Fistonich1, Sandra Zehentmeier1, Jeffrey J. Bednarski2, Runfeng Miao1, Hilde Schjerven3, Barry P. Sleckman4, and João P. Pereira1

B cell progenitors require paracrine signals such as interleukin-7 (IL-7) provided by bone marrow stromal cells for
proliferation and survival. Yet, how B cells regulate access to these signals in vivo remains unclear. Here we show that proB
and IL-7+ cells form a cell circuit wired by IL-7R signaling, which controls CXCR4 and focal adhesion kinase (FAK) expression
and restricts proB cell movement due to increased adhesion to IL-7+CXCL12Hi cells. PreBCR signaling breaks this circuit by
switching the preB cell behavior into a fast-moving and lower-adhesion state via increased CXCR4 and reduced FAK/α4β1
expression. This behavioral change reduces preB cell exposure to IL-7, thereby attenuating IL-7R signaling in vivo. Remarkably,
IL-7 production is downregulated by signals provided by preB cells with unrepaired double-stranded DNA breaks and by
preB acute lymphoblastic leukemic cells. Combined, these studies revealed that distinct cell circuits control the quality
and homeostasis of B cell progenitors.

Introduction

B cell development is highly dependent on IL-7 receptor signaling
mediated by IL-7 (Grabstein et al., 1993; Peschon et al., 1994; von
Freeden-Jeffry et al., 1995; Puel et al., 1998; Carvalho et al., 2001).
At the proB cell stage, IL-7R signals mostly through the JAK1/3
and STAT5a/b pathway to promote survival and proliferation.
However, at the preB cell stage, IL-7R signaling plays both positive and negative roles in B cell development. It is still required
for preB cell proliferation and anti-apoptotic gene expression
(e.g., Bcl2, Bcl2l1, and Mcl1). Yet, it also inhibits Igκ germline
transcription through STAT5 binding of Eκi and recruitment of
Polycomb repressive complex 2, which results in histone H3 lysine 27 trimethylation and inaccessibility of Jκ and Cκ regions
to the RAG proteins (Mandal et al., 2011). Furthermore, IL-7R–
induced cyclin D3 expression negatively regulates Vκ transcription, resulting in inhibited RAG protein accessibility to the Vκ
genes (Powers et al., 2012). IL-7R signaling in preB cells has also
been proposed to repress Rag1 and Rag2 transcription (Johnson
et al., 2008) through phosphatidylinositol-3-OH kinase (PI3K)
activation, AKT phosphorylation, and Foxo1 inactivation (Ochiai
et al., 2012). Thus, IL-7R signaling simultaneously promotes preB
cell survival and proliferation while also profoundly inhibiting
IgL chain gene rearrangement and developmental progression
into the immature B cell stage. How can preB cells then balance

positive and negative effects of IL-7R signaling to allow developmental progression in vivo?
Some evidence suggests that preB cell receptor (preBCR) signaling activates IRF4 expression (Thompson et al., 2007). In addition
to enabling IgL gene rearrangement, IRF4 promotes CXCR4 expression and increases preB cell migration toward CXCL12 (Johnson
et al., 2008). BCR signaling at the immature B cell stage also promotes CXCR4 upregulation and increases B-lineage cell migration
to CXCL12 in vitro and in vivo (Beck et al., 2014). Initial attempts to
identify bone marrow (BM) stromal cell subsets that express IL-7
and CXCL12, using an anti–IL-7 antibody and Cxcl12GFP/+ reporter
mice, concluded that nonhematopoietic CXCL12-GFPHi stromal cells
did not express IL-7. Reciprocally, cells detected with an anti–IL-7
antibody were not marked by Cxcl12-driven GFP expression. It was
therefore concluded that two distinct stromal cell subsets existed
in the BM of adult mice that expressed either IL-7 or CXCL12, but
not both (Tokoyoda et al., 2004). In light of these findings, Singh
and colleagues proposed that preBCR-mediated upregulation of
CXCR4 localizes preB cells near CXCL12-producing cells and, in this
manner, lowers IL-7R signaling by positioning preB cells in IL-7low
microenvironments (Johnson et al., 2008). This model gained traction because it provided a reasonable explanation for how preB cells
coordinate positive and negative roles of IL-7R signaling in vivo
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Results

Overlapping BM niches for proB and preB cells
Although proB and preB cells can be readily distinguished by flow
cytometry using a variety of cell surface markers (Fig. 1 A), these
Fistonich et al.
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phenotypic differences were insufficient for their reliable visualization in situ (not shown). To overcome this limitation, we took
advantage of the fact that proB cells express significantly higher
amounts of Rag1 and Rag2 than preB cells and used RAG2:GFP
knock-in mice (Monroe et al., 1999) to examine the distribution
of proB and preB cells in vivo. As expected, cKit+ CD19+ CD93Hi
IgM− proB cells expressed bimodal and notoriously high amounts
of RAG2:GFP, whereas cKit− CD19+ CD93Hi IgM− preB cells expressed detectable but significantly lower amounts of RAG2:GFP
(Fig. 1 B). A short, 20-min pulse in vivo with the thymidine analogue BrdU confirmed that RAG2:GFP is predominantly abundant
in BrdU-negative proB and preB cells (Fig. 1 B), in agreement with
studies showing active RAG2 phosphorylation, ubiquitination,
and degradation during the S phase of the cell cycle (Desiderio,
2010). To examine the distribution of proB and preB cells in relation to CXCL12 and IL-7+ mesenchymal progenitor cells (MPCs),
we reconstituted lethally irradiated Il7GFP/+ Cxcl12dsred/+ mice with
BM cells isolated from RAG2:GFP knock-in mice. Analyses of
femur whole mounts by confocal microscopy revealed that RAG2:
GFPHi B-lineage cells were slightly closer to CXCL12+ IL-7+ MPCs
than RAG2:GFPLo B cells, whereas the distribution of RAG2:GFPLo
B cells was similar to that of randomly picked CD19− cells marked
by DAPI+ nuclei (Fig. 1, C and D). Furthermore, ∼50% of RAG2:
GFPHi proB cells (29 out of 62) were found in direct contact with a
CXCL12+ IL-7+ cell that also directly interacted with a RAG2:GFPLo
preB cell, although only ∼15% of RAG2:GFPLo preB cells (40 out of
284) in contact with a CXCL12+ IL-7+ cell had a neighboring RAG2:
GFPHi proB cell (Fig. 1 E).
Next, we analyzed mice in which B cell development is blocked
at the proB (Rag1−/−) and at the preB (Rag1−/− IghB1-8/+) cell stage.
As before, we generated BM chimeras by transplanting BM cells
from either mice into lethally irradiated Il7GFP/+ Cxcl12dsred/+ mice
and analyzed proB and preB cell distribution in femur whole
mounts by confocal microscopy. ProB cells were found in direct
contact with IL-7+ CXCL12+ stromal cells at slightly but significantly higher frequencies than preB cells (Fig. 1, F and G). In summary, while the large majority of proB and preB cells occupy IL-7
niches, a small fraction of preB cells is more frequently found in
niches farther away from IL-7+ cells.
ProB and preB cell dynamic behavior in vivo
Next, we sought to understand the mechanisms by which preB
cells position away from IL-7–expressing cells, with the broader
goal of understanding whether positional differences in B cell
precursors are physiologically important. To gain insight into
how proB and preB cells localize in the BM, we visualized their
behavior in vivo by intravital two-photon microscopy, as previously described (Pereira et al., 2009). We generated mice
in which proB cells are labeled genetically with Rag1GFP/GFP (B
cell development is arrested at the proB cell stage) and mice
in which preB cells are similarly labeled but development is
allowed to proceed until the preB cell stage due to transgenic
expression of a recombined heavy chain locus (Igh3-83/+). While
proB cells were predominantly static and in direct contact with
CXCL12+ cells, with a few proB cells migrating short distances,
nearly all preB cells were motile (Fig. 2 A and Video 1). PreB
cells displayed increased median velocity (Fig. 2 B) and mean
Journal of Experimental Medicine
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(Clark et al., 2014). However, blinded analyses of IL-7–producing
cells in tissue sections of wild-type and IL-7–deficient mice stained
with an anti–IL-7 antibody failed to reliably identify IL-7+ cells,
and, since then, multiple IL-7 reporter mice have been generated
(Mazzucchelli et al., 2009). Using Il7GFP/+ knock-in mice and Il7-CFP
transgenic mice in combination with Cxcl12dsRed/+ reporter mice, we
identified a nonhematopoietic Lepr+ cell subset with mesenchymal
progenitor potential that not only expressed IL-7 but also expressed
the highest amount of CXCL12 of all BM cells (Cordeiro Gomes et
al., 2016). Furthermore, hematopoietic multipotent progenitor cells
and common lymphoid progenitor cells are strictly dependent on
CXCR4 for optimal IL-7R signaling and consequently for lymphoid
lineage development. However, these findings raise the possibility
that preBCR signaling would actually promote preB cell localization
near CXCL12Hi cells where IL-7–production is highest. Thus, how
preB cells regulate this juxtaposition between preBCR and IL-7R
signaling to successfully progress into the immature and mature B
cell stages still remains enigmatic (Lim et al., 2017).
The behavior of proB and preB cells in vivo is presumably
physiologically relevant also in extreme situations such as when
B cell precursors cannot repair double-stranded DNA breaks
(DSBs). Indeed, unrepaired RAG-mediated DSBs result in the activation of NF-κB and SpiC-controlled gene expression programs
that downregulate preBCR signaling components and upregulate
the expression of genes involved in lymphocyte migration and
adhesion (Bredemeyer et al., 2008; Bednarski et al., 2016). Furthermore, Ikaros-deficient proB cells and both mouse and human
Ikaros-deficient BCR-ABL–expressing preB acute lymphoblastic
leukemic (preB-ALL) cells are aberrantly adherent to stromal
cells (Joshi et al., 2014; Schwickert et al., 2014; Schjerven et al.,
2017). Thus, understanding how normal and DSB-damaged proB
and preB cells behave in vivo and interact with BM niches can
lead to novel insights into B cell development and homeostasis.
Here we show that proB cells are essentially nonmotile and
intimately associated with CXCL12+ IL-7+ mesenchymal cells.
CXCL12 guides proB cells toward IL-7Hi niches that in turn activate IL-7R signaling to promote CXCR4 and focal adhesion kinase
(FAK; encoded by Ptk2) expression. This enforces proB cell/IL-7+
cell interactions and favors IL-7–mediated proB cell expansion.
PreBCR signaling then breaks this circuit by further increasing
CXCR4 expression while substantially lowering α4β1/FAK-mediated adhesion to VCAM-1. Consequently, preB cells spend little
time in direct contact with CXCL12- and IL-7–producing cells,
attenuating IL-7R signaling in vivo. Remarkably, IL-7+ niche cells
modulate IL-7 production in response to the quality of neighboring preB cells: preB cells with unrepaired DSBs and BCR-ABL+
preB-ALLs instruct IL-7+ niche cells to decrease IL-7 and CXCL12
production, which significantly reduces endogenous B lymphopoiesis. These findings provide evidence supporting a model in
which cell circuits operate in the BM to control the number and
quality of B cell precursors.
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displacement (Fig. 2 C) when compared with proB cells. This
drastic difference in dynamic behavior was also reflected in
the prolonged time individual proB cells spent in contact with
CXCL12+ cells throughout a 30-min imaging period (Fig. 2 D),
as well as in an increased average time individual proB cells
spent in contact with individual CXCL12+ cells when compared
with preB cells (Fig. 2 E). These observations showed that the
small differences found in proB and preB cell static positioning
in situ (Fig. 1) were caused by dramatically different dynamic
Fistonich et al.
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Figure 1. Localization of proB and preB cells in relationship to IL-7– and CXCL12-producing cells. (A) Gating strategy for proB and preB cells. Left, BM
cells gated on live CD19+ cells. Right, cKit expression distinguishes proB from preB cells. (B) Left, RAG2:GFP fusion protein expression in proB (red) and preB
(blue) cells isolated from RAG2:GFP mice. Filled histograms show background fluorescence in wild-type preB cells. RAG2:GFP expression in proB (middle
panel) and preB (right panel) in S phase (BrdU+) and in non–S phase (BrdU–). (C) Longitudinal 30-µm-thick femur section from lethally irradiated Il7GFP/+
Cxcl12dsRed/+ mouse reconstituted with RAG2:GFP BM cells stained to detect GFP (green), CD19 (cyan), and nuclei (DAPI, not shown). Cxcl12-dsRed fluorescent
protein (red) was directly visualized. Data were pooled from two independent experiments (n = 2). (D) Quantification of proB (RAG2:GFPHi) and preB (RAG2:
GFPLo) cells in contact with IL-7– and CXCL12-producing cells (see Materials and methods for details). Bars indicate average; circles indicate individual mice.
(E) Quantification of colocalized RAG2:GFPHi (proB) and RAG2:GFPLo (preB) in contact with individual IL-7+ CXCL12+ cells (bottom right). Example of a RAG2:
GFPHi (arrowheads) and a RAG2:GFPLo (arrows) cell in contact with the same IL-7+ cell. The same datasets were analyzed as in D. Error bars indicate SD. (F)
Longitudinal 30-µm-thick section of a femur from a lethally irradiated Il7GFP/+ Cxcl12dsRed/+ mouse reconstituted with Rag1−/− (top panels) or Rag1−/− IghB1-8/+
(bottom panels) BM cells, stained to detect GFP (green) and CD19 (cyan). Cxcl12-dsRed was directly visualized (red). An entire femur/mouse was acquired;
data were pooled from three independent experiments (n = 3). (G) Frequency of proB (Rag1−/−) and preB (Rag1−/− IghB1-8/+) cells in contact with IL-7+ CXCL12+
cells. Bars indicate average; circles depict individual mice. *, P < 0.05 by unpaired Student’s t test. Scale bars, 50 µm. Data in all panels are representative of
two to five independent experiments.

behaviors in vivo, and suggest that they might be physiologically relevant.
As developing B cell migration in vivo is controlled by CXCR4
(Beck et al., 2014), we measured CXCR4 expression in proB and
preB cells and migration in vitro using a transwell assay. Indeed,
CXCR4 expression is enhanced in preB cells (Fig. 3 A), and preB
cells migrated toward a gradient of CXCL12 significantly more
than did proB cells (Fig. 3 B). Nevertheless, this relatively small
difference in migration toward CXCL12 in vitro contrasted with a
Journal of Experimental Medicine
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remarkably different dynamic behavior in vivo, suggesting that additional mechanisms might be involved in vivo. Other than CXCR4,
B-lineage cells required α4β1 integrin-mediated adhesion to
VCAM-1 for retention and migration within the BM (Pereira et al.,
2009; Beck et al., 2014), and proB cells expressed higher amounts
of α4β1 than preB cells (Fig. 3 C). Previous studies showed that the
transcription factor Ikaros acts as a transcriptional repressor of
multiple genes involved in cell migration and adhesion (Schjerven
et al., 2013; Joshi et al., 2014; Schwickert et al., 2014), of which FAK
(encoded by Ptk2) played a major role in supporting aberrant proB
cell adhesion to stromal cells and VCAM-1 in vitro (Schwickert et
al., 2014). FAK is also required for the retention of Ikaros-sufficient proB cells in the BM (Park et al., 2013). Interestingly, proB
cells expressed significantly higher amounts of FAK (and Ikaros)
than preB cells (Fig. 3, D and E), suggesting that proB cells might be
more adherent to VCAM-1 than preB cells. To test this hypothesis,
we coated transwells with a range of VCAM-1 concentrations and
quantified proB and preB cell migration toward a CXCL12 gradient in vitro. As expected, VCAM-1–mediated adhesion prevented
proB cell migration significantly more than in preB cells (Fig. 3 F).
Combined, these data strongly suggest that the reduced migratory
behavior of proB cells is due to a small reduction in CXCR4 expression in combination with increased FAK/α4β1 integrin-mediated
adhesion to VCAM-1.
ProB cell/IL-7+ cell circuits control IL-7R signaling
The observation that proB cells are predominantly nonmotile
and stably adherent to BM IL-7– and CXCL12-producing MPCs
suggests that IL-7R signaling is constitutively high in proB cells,
Fistonich et al.
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Figure 3. CXCR4-mediated migration and VLA4/FAK-mediated adhesion to VCAM-1 in proB and preB cells. (A) CXCR4 expression in proB and
preB cells. (B) In vitro transwell (5-µm pore) migration assay of C57BL/6 BM
cells toward CXCL12 gradients. Y axis indicates frequency of migrated cells; x
axis shows CXCL12 concentration (nanograms per milliliter). (C) α4 integrin
expression in proB and preB cells. (D) FAK expression (encoded by Ptk2) in
proB and preB cells. (E) Ikaros (encoded by Ikzf1) expression in proB and preB
cells. (F) ProB and preB cell migration across VCAM-1–coated transwells (5
µm) toward CXCL12 gradient (300 ng/ml). Y axis indicates percent reduction
in migratory cells; x axis shows VCAM-1 concentration (micrograms per milliliter) used for coating transwells. (B and F) Error bars indicate SD of three
individual experiments. Numbers inside all histograms indicate geometric
mean fluorescence intensity ± SD (n = 3 mice in each group). *, P < 0.05 by
unpaired Student’s t test. Data in all panels are representative of three to five
independent experiments.
Journal of Experimental Medicine
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Figure 2. ProB and preB cell migratory behavior in vivo. (A) Distribution of GFP+ proB cells (green, top left) and of preB cells (green, bottom left) in BM
calvaria of lethally irradiated Cxcl12dsRed/+ mice reconstituted with Rag1GFP/GFP (top panels) or with Rag1GFP/GFP Igh3-83/+ (bottom panels) BM cells. Movement
of GFP+ B cells tracked for 30 min in vivo by IVM. Colored lines (right panels) represent cell trajectories. Scale bar, 50 µm. (B) Median velocity (micrometers
per minute). Each circle represents a single cell analyzed. (C) Mean motility coefficient of proB and preB cells. Cell displacement from starting coordinates is
plotted against time (minutes). Lines represent the mean motility coefficient from three separate videos per mouse. (D) Time (minutes) spent in direct contact
with CXCL12+ cells over 30 min. (E) Average time (minutes) proB and preB cells spent in contact with individual CXCL12+ cells. Data are from Video 1. Circles
represent single cells analyzed. ****, P < 0.00005 by unpaired Student’s t test. Data in all panels are representative of three independent experiments.
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PreBCR signaling breaks the proB/IL-7+ cell circuit to attenuate
IL-7R signaling at the preB cell stage
In addition to signaling from the preBCR, the transition from
a constitutively high to an intermittent and low IL-7Ra signaling from proB to preB cells has been proposed to control
Fistonich et al.
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RAG gene expression and Ig light chain gene accessibility
(Johnson et al., 2008; Ochiai et al., 2012; Clark et al., 2014). We
reasoned that the rapid movement and reduced time spent in
contact with CXCL12 and IL-7+ MPCs might enable preB cells
to attenuate IL-7R signaling in vivo. Furthermore, as preBCR
signaling induces IRF4 expression and IRF4 drives CXCR4 upregulation (Muljo and Schlissel, 2003; Thompson et al., 2007;
Johnson et al., 2008), we hypothesized that preBCR signaling
is also responsible for the switch from higher to lower FAK/
α4β1 integrin-mediated adhesion to VCAM-1. Indeed, preB cells
treated with a cocktail of SYK and BTK inhibitors (fostamatinib and ibrutinib, respectively) or the PI3K inhibitor wortmannin promoted α4β1 and FAK expression (Fig. 5, A and B),
whereas stimulatory anti-CD79b antibody treatment reduced
α4β1 and FAK expression (Fig. 5, C and D), increased CXCR4 expression in preB cells (data not shown), and increased preB cell
migration toward CXCL12 (Fig. 5 E). The changes induced by
anti-CD79b stimulation, albeit also small, were significant and
sufficient for causing significant differences in α4β1-mediated
preB cell adhesion to VCAM-1 in vitro (Fig. 5 F). These findings suggested that preB cells acquire rapid motility through
the combined small but significant and physiologically relevant changes in CXCR4, α4β1, and FAK expression in vivo. To
test this possibility, we took advantage of the fact that Philadelphia chromosome–positive BCR-ABL preB-ALL cells are
developmentally arrested at the preB cell stage (Schjerven et
al., 2017) to measure the effects of increased FAK signaling in
preB cell behavior in vivo. Indeed, preB-ALL cells retrovirally
transduced with a Ptk2 expression vector significantly reduced
their migratory behavior in vivo at day 7 after transplantation
(Fig. 5, G–I; and Video 3) and increased their time in contact
with CXCL12Hi stromal cells (Fig. 5, J and K). Combined, these
findings suggest that productive V(D)J rearrangements in proB
cells and signaling through the newly assembled preBCR acts
as a proB/IL-7+ cell circuit breaker through increased CXCR4
expression and decreased integrin-mediated adhesion, which
promotes rapid movement between IL-7Hi and IL-7Lo BM microenvironments (Fig. 5 L). These results are consistent with
studies showing differential adhesion of B cell precursors to
VCAM-1 in vitro (Glodek et al., 2003).
Such tight control of preB cell dynamic behavior in vivo lends
support to the long proposed but never tested hypothesis that
CXCR4-regulated positioning attenuates IL-7Ra signaling required for Rag gene reexpression and developmental progression into the immature B cell stage (Johnson et al., 2008; Clark
et al., 2014). To experimentally test this model, we antagonized
the FAK downregulation that normally occurs at the preB cell
stage by overexpressing Ptk2 (reported by GFP expression) in
hematopoietic stem cell (HSC)–enriched BM cells from C57BL/6
mice and analyzed B cell developmental subsets in FAKHi versus control transduced cells. Lethally irradiated recipient mice
were reconstituted with empty vector (EV)– or Ptk2-transduced
HSCs for a period of 4–6 wk. Hematopoietic progenitor cells overexpressing FAK showed a strong inability to differentiate into
blood cell types in vivo for unknown reasons, but a few FAKHi
lymphoid and myeloid cells could nevertheless be detected in the
BM. Approximately twofold overexpression of FAK was achieved
Journal of Experimental Medicine
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which led us to hypothesize that IL-7R signaling might, in turn,
regulate the expression of genes involved in proB cell localization
and dynamic behavior. To test this hypothesis, we conditionally
deleted IL-7Ra in proB cells by crossing Il7rafl/fl mice with Mb1cre/+
mice. B cell development was severely impaired at the proB and
preB cell stages, which led to an overall reduction in total B cell
numbers (Fig. 4 A). We confirmed by flow cytometry that IL-7R
protein expression was not detected on the few proB and preB
cells that could be found in the BM of Il7rafl/fl Mb1cre/+ mice (data
not shown). Interestingly, we noted that the proportion of IL7Ra–deficient proB and preB cells in the spleen was higher than
that seen in the spleen of littermate control mice (Fig. 4 B), suggesting that IL-7Ra–deficient B-lineage precursors might be less
retained in the BM than wild-type counterparts. The few IL-7Ra–
deficient B-lineage cells that nevertheless developed expressed
significantly reduced amounts of CXCR4 in proB and preB cells
(Fig. 4 C and data not shown, respectively). Furthermore, IL-7Ra–
deficient proB and preB cells migrated toward CXCL12 in vitro
with lower efficiency than IL-7Ra–sufficient proB and preB cells,
while IL-7Ra deficiency had no impact on migration to CXCL12 (or
CXCR4 expression) in immature B cells that no longer expressed
IL-7Ra (Fig. 4 D and data not shown, respectively). To further validate these findings, we measured the impact of IL-7Ra signaling on motility and adhesion mechanisms of wild-type proB and
preB cells developing in vivo. Indeed, IL-7Ra signaling actively
controlled the proB adhesion program as measured by significantly reduced FAK expression after treatment with an anti–IL7Ra blocking antibody (clone A7R34) for 36 h (Fig. 4 E), whereas
α4β1 expression was unchanged (Fig. 4 F). Similar changes were
observed in IL-7Ra–deficient proB cells (data not shown). To
test if IL-7Ra signaling also controls proB cell behavior in vivo,
we analyzed proB cell motility in Rag1GFP/GFP mice treated with
IL-7Ra blocking antibodies for 36 h by intravital two-photon microscopy. Although the majority of proB cells remained largely
sessile, we could detect a subtle but significant increase in the
mean displacement and median cell velocity of proB cells treated
with anti–IL-7R antibody (Fig. 4, G and H; and Video 2) that did
not seem to be caused by active, amoeboid cell motility, given that
proB cells became more rounded (Fig. 4 I) and presumably less
adherent to the extracellular matrix. In agreement with this possibility, proB cells became slightly less associated with CXCL12+
cell processes (Fig. 4 J). Loosely adherent proB cells likely become
more motile as a consequence of shear stress generated by intrasinusoidal turbulent blood flow and plasma transudation
into BM parenchyma (Beck et al., 2014). We propose that CXCR4
and integrin signaling (α4β1/FAK/VCAM-1) locks proB cells in
contact with IL-7–producing cells in BM. This tight interaction
likely drives constitutive IL-7Ra signaling that further promotes
CXCR4 and FAK/α4β1 integrin-mediated adhesion to IL-7–producing cells (Fig. 4 K) in a feed-forward loop manner that resembles a two-cell circuit system (Zhou et al., 2018).
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in Ptk2-transduced preB cells, which made it equivalent to that
detected in EV-transduced proB cells (Fig. 6 A). Furthermore,
FAKHi preB cells showed significantly higher amounts of phosphorylated STAT5a than EV-transduced preB cells (Fig. 6 B),
suggesting that FAKHi preB cells may have been more exposed
to IL-7 in vivo. Interestingly, the frequency of FAKHi cells within
the preB cell and subsequent B cell subsets was fourfold lower
than FAKHi cells within the proB stage (Fig. 6 C). We cannot rule
out the possibility that increased FAK signaling prevents preB
cell proliferation. However, these findings suggest that antagonism of the normal FAK downregulation that occurs at the preB
cell stage blocks the transition between the proB and preB cell
stages, which significantly reduces mature B cell production in
Fistonich et al.
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vivo. To validate these findings and to gain further insight, we
asked if proximity to IL-7 alters the preB cell cycle and perturbs
RAG2 protein stability in vivo. To address this question, we overexpressed the R334X desensitization mutant form of CXCR4 that
causes WHIM (warts, hypogammaglobulinemia, infections, and
myelokathexis) syndrome (Gorlin et al., 2000; Hernandez et al.,
2003; Balabanian et al., 2005) in HSCs isolated from RAG2:GFP
mice and reconstituted lethally irradiated recipient mice with
EV- or CXCR4R334X-transduced HSCs for a period of 4–6 wk.
CXCR4R334X-transduced preB cells expressed higher amounts of
CXCR4 than EV-transduced preB cells (Fig. 6 D). Interestingly,
overexpression of the CXCR4R334X mutant increased the fraction
of preB cells that was in the S phase of the cell cycle, as measured
Journal of Experimental Medicine
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Figure 4. Relationship between IL-7R signaling and CXCR4-mediated proB cell motility. (A) Total number of developing B cell subsets from femur and
tibia (left) and from spleen (right) of mice conditionally deficient in IL-7Ra in B-lineage cells: Mb1Cre/+ Il7raFl/+ (black) and Mb1Cre/+ Il7raFl/Fl (gray) mice. (B) Mobilization index: ratio of proB and preB cell number in the spleen to that in the BM of Mb1Cre/+ Il7raFl/+ (Het, black) and Mb1Cre/+ Il7raFl/Fl (KO, gray) mice. Circles
depict individual mice. (C) CXCR4 geometric mean fluorescence intensity (GMFI) in proB cells (left) and preB cells (right) gated as in A in Mb1Cre/+ Il7raFl/+ (Het,
black) and Mb1Cre/+ Il7raFl/Fl (KO, gray) mice. (D) In vitro transwell (5 µm) migration assay of Mb1Cre/+ Il7raFl/+ (Het, black) and Mb1Cre/+ Il7raFl/Fl (KO, gray) BM
cells toward CXCL12 gradients. Y axis indicates frequency of migrated cells; x axis shows CXCL12 concentration (nanograms per milliliter). (A–D) Lines indicate
mean; circles depict individual mice (n = 3). (E) FAK expression in proB cells isolated from C57BL/6 mice untreated (littermate controls, black) or treated with
anti–IL-7Ra blocking antibodies (gray) for 36 h. (F) α4 integrin expression in proB cells isolated from C57BL/6 mice treated with isotype control (black) or anti–
IL-7Ra blocking antibody (gray) for 36 h. (E and F) Numbers inside histograms indicate geometric mean fluorescence intensity ± SD (n = 3 mice in each group).
(G) Mean motility coefficient of proB cells in mice untreated (black) or treated with IL-7Ra blocking antibodies (gray) for 36 h. GFP+ proB cells were visualized
in calvaria of lethally irradiated Cxcl12dsRed/+ mice reconstituted with BM cells from Rag1GFP/GFP mice. ProB cell movement was tracked for 30 min in vivo by
IVM. Lines represent the mean motility coefficient from three separate videos per mouse. (H) Median velocity. Circles, individual cells. (I) Measurement of cell
axis ratio of GFP+ proB cells before (black) and after (gray) treatment with anti–IL-7Ra blocking antibody. Each point represents an individual cell analyzed. (J)
Frequency of GFP+ proB cells found in contact with Cxcl12-dsRed cells in mice treated with IL-7Ra blocking antibody (gray) or untreated (black). Circles, average
from individual fields of view. (K) Model of the proB/IL-7+ cell circuit. *, P < 0.05; **, P < 0.005; ***, P < 0.0005; ****, P < 0.00005 by unpaired Student’s t test.
Data in all panels are representative of two to four independent experiments.
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by a 20-min pulse of BrdU incorporation in vivo (Fig. 6 E). As
expected, it also reduced the fraction of RAG2:GFPHi preB cells
(Fig. 6, F and G). These findings suggest that enforcement of
preB cell interactions with IL-7+ cells is sufficient for reducing
the time preB cells spend in the G1 phase of the cell cycle and
hence to perturb RAG2 protein stability. These changes were
reflected in a significant expansion of CXCR4R334X-Hi proB cells
when compared with granulocytes (Fig. 6 H), a result that is consistent with increased IL-7R signaling due to increased exposure
to IL-7 (Carvalho et al., 2001; Rother et al., 2016). In contrast,
CXCR4R334X-Hi preB cells were reduced by threefold, presumably
due to reduced RAG2 protein half-life and time spent in the G1
phase of the cell cycle. This led to a greater than threefold reduction in the generation of CXCR4R334X-Hi mature B cells (Fig. 6 H).
Reduced granulocyte production from CXCR4R334X-Hi progenitors
is likely a consequence of reduced differentiation capacity of
HSCs that express CXCR4 desensitization mutant (McDermott
et al., 2015; Freitas et al., 2017).
Fistonich et al.
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Preleukemic preB and BCR-ABL preB cells regulate IL-7
production in vivo
Previous studies suggested that RAG-mediated DSBs elicit an
NF-κB–driven and Spic-driven gene expression program in preB
cells that downregulates the expression of preBCR signaling
components and upregulates the expression of genes involved
in cell migration (Bredemeyer et al., 2008; Bednarski et al.,
2016). Thus, we reasoned that the accumulation of unrepaired
DSBs that occurs in Artemis (encoded by Dclre1c)-deficient preB
cells might alter their distribution in relationship to IL-7+ cells
in vivo. To address this question, we compared the distribution
of Igh and Bcl2 transgenic Rag1−/− preB cells (no RAG-mediated
DSBs) and of Igh and Bcl2 transgenic Dclre1c−/− preB cells (accumulated unrepaired DSBs) relative to IL-7+ and CXCL12+ cells.
However, we did not detect significant differences in Artemis-deficient and -sufficient preB cells in vivo (Fig. 7, A and B), which
was consistent with no measurable differences in CXCR4 expression (Fig. 7 C). Unexpectedly, we noted that Il7 expression was
Journal of Experimental Medicine
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Figure 5. Relationship between preBCR signaling and CXCR4- and integrin-mediated preB cell motility. (A) FAK geometric mean fluorescence intensity
(GMFI) in preB cells from C57BL/6 mice treated with BCR signaling inhibitors (blue, fostamatinib and ibrutinib) or vehicle (red), or with PI3K inhibitor wortmannin
(green) or vehicle (red) for 6 h in vitro. (B) α4 integrin expression in preB cells of C57BL/6 mice treated as in A. Numbers indicate geometric mean fluorescence
intensity ± SD (n = 3 mice per condition). (C and D) FAK geometric mean fluorescence intensity (C) and α4 integrin expression (D) in preB cells treated with
stimulatory CD79b antibody for 6 h in vitro. Con., control. (A and C) Bars indicate mean; circles depict individual mice/assays. (D) Numbers inside histogram
indicate geometric mean fluorescence intensity ± SD (n = 3 individual mice/assays). (E) Transwell migration toward CXCL12 of preB cells treated with stimulatory CD79b antibody for 6 h in vitro. Y axis indicates frequency of migrated cells; x axis indicates CXCL12 concentration (nanograms per milliliter). (F) PreB cell
migration across VCAM-1–coated transwells (5 µm) toward CXCL12 gradient (300 ng/ml). Y axis indicates percent reduction in migrated cells; x axis indicates
VCAM-1 concentration (micrograms per milliliter) used for coating transwells. (E and F) Circles represent average of three independent experiments. Error
bars indicate SD. (G) Distribution of EV-transduced GFP+ preB-ALL cells (green, top left) and of FAK-transduced GFP+ preB-ALL cells (green, bottom left) in
BM calvaria of Cxcl12dsRed/+ mice at day 14 after transplantation. Movement of GFP+ B cells tracked for 30 min by IVM. Colored lines represent cell trajectories
(right panels). Scale bar, 50 µm. (H) PreB-ALL cell velocity (micrometers per minute). Each circle represents a single cell analyzed. (I) Mean motility coefficient
of EV- and FAK-transduced preB-ALL cells. Cell displacement from starting coordinates is plotted against time (minutes). Lines depict the mean motility
coefficient from three videos imaged/mouse. (J) Time (minutes) spent in direct contact with CXCL12+ cells over a 30-min period. (K) Average time (minutes)
that EV- and FAK-transduced preB-ALL cells spent in direct contact with individual CXCL12+ cells. (J and K) Circles represent single cells. Data in panels G–K
are from Video 3. (L) Model of the preB/IL-7+ cell circuit. **, P < 0.005; ***, P< 0.0005; ****, P < 0.00005 by unpaired Student’s t test. Data in all panels are
representative of two to four independent experiments.
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lower in MPCs isolated from the BM of mice in which preB cells
were deficient in Artemis (Fig. 7, D and E), suggesting that IL-7+
cells sense the quality of neighboring preB cells through signals
provided by Artemis-deficient preB cells. As Artemis deficiency
is a risk factor for leukemogenesis, we finally asked if bona fide
preB-ALLs also regulate IL-7 production in BM. We adoptively
transferred 105 BCR-ABL preB-ALL cells into nonirradiated
Cxcl12dsRed/+ Il7GFP/+ mice and measured Il7-GFP and Cxcl12-dsRed
expression in MPCs 2 wk after transfer. Remarkably, Il7-GFP and
Cxcl12-dsRed expression was significantly reduced in mice recipient of BCR-ABL preB-ALLs (Fig. 7, F–I). Furthermore, terminal deoxynucleotidyl transferase expression was significantly
reduced in nonleukemic proB cells (Fig. 7, J and K), consistent
with reduced IL-7R signaling in these cells (Wei et al., 2000;
Carvalho et al., 2001; Rother et al., 2016). These changes resulted
in a threefold reduction in endogenous nonleukemic B cell production (Fig. 7 L), while granulocytes were only reduced by ∼20%
Fistonich et al.
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(Fig. 7 M). Combined, these results suggest that preB/IL-7+ cell
circuits evolved to not only regulate preB cell transition into the
immature B cell compartment, but also to facilitate the removal
of dangerous preleukemic preB cells (Fig. 7 N).

Discussion

B lymphocyte progenitors have been proposed to occupy distinct
microenvironments in the BM according to their developmental
stage (Dorshkind, 1990; Jacobsen and Osmond, 1990; Pereira et
al., 2009; Mourcin et al., 2011). ProB cells are highly dependent
on extrinsic growth factors (mostly IL-7, stem cell factor, and possibly FLT3 ligand) for survival and proliferation (Grabstein et al.,
1993; Peschon et al., 1994; von Freeden-Jeffry et al., 1995; Waskow
et al., 2002; Sitnicka et al., 2003). Most, if not all, of these factors
are produced by Leptin receptor (Lepr)–positive nonhematopoietic cells that express the highest amounts of CXCL12 in the BM
Journal of Experimental Medicine
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Figure 6. Relationship between enforced positioning within IL-7+ niches, RAG2 protein stability, and preB cell developmental progression. (A) Overexpression of FAK (Ptk2) or EV reported by GFP in retrovirally transduced BM cells isolated from C57BL/6 mice. FAK expression in preB cells transduced with
EV (left) or FAK (middle). Representative histogram of preB cells transduced with FAK compared with proB cells transduced with EV (right). (B) pSTAT5a in
EV- or FAK-transduced preB cells. (C) Frequency of EV- (left) or FAK-transduced (right) GFPHi BM B-lineage cells and granulocytes from femur and tibia. (D)
Overexpression of CXCR4 R334X (WHIM mutation) in retrovirally transduced BM cells isolated from RAG2:GFP knock-in mice. Transduced cell subsets reported
by human CD4. CXCR4 expression in EV- (left) or CXCR4R334X-transduced (right) preB cells gated on hCD4Lo and hCD4Hi cells. (E) BrdU incorporation in EV- (left)
or CXCR4R334X-transduced preB cells. Numbers indicate the frequency of BrdU+ cells. (F) RAG2:GFP expression in gated hCD4Hi and hCD4Lo preB cells (EV, left;
CXCR4R334X, right). (G) Quantification of RAG2:GFP fusion protein geometric mean fluorescence intensity (GMFI). Circles depict individual mice. (H) Frequency
of hCD4Hi B-lineage cells and granulocytes in femur and tibia BM. Circles indicate mean ± SD (n = 3). (C and H) Error bars indicate SD of three independent
experiments. Numbers inside histograms (A, B, and D) indicate geometric mean fluorescence intensity ± SD (n = 3 mice in each group). Data in all panels were
pooled from three independent experiments. *, P < 0.05; **, P < 0.01 by unpaired Student’s t test (C and H). *, P < 0.05 by paired Student’s t test (G).
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(Ding et al., 2012; Cordeiro Gomes et al., 2016). In later stages,
preB cell survival and proliferation continue to depend on IL-7,
albeit to a lower extent than proB cells due to pro-survival and
pro-proliferative signals mediated by the preBCR (Clark et al.,
2014). However, IL-7R signaling also prevents preB cell developmental progression by inhibiting Rag gene expression and Ig
light chain gene accessibility (Ochiai et al., 2012). Therefore, it
was unclear how preB cells achieve an appropriate level of IL-7R
signaling that allows cells to developmentally progress in vivo.
Here we show that proB and preB cells display remarkably different dynamic behaviors in vivo. ProB cells are predominantly
nonmotile and intimately associated with IL-7+ cells. IL-7R signaling controls this stable cell–cell interaction by promoting high
CXCR4 and FAK expression. This type of feed-forward regulation
resembles an unstable two-cell circuit (Zhou et al., 2018) in that
it would predict uncontrolled proB cell growth under normal
homeostatic conditions. Instead, our data suggest that cell circuit stability is partly ensured by preBCR signaling, which acts
as a circuit breaker by altering the behavior of preB cells in vivo.
Importantly, this is achieved through a relatively subtle increase
in CXCR4 expression and reduction in α4β1/FAK expression.
These combined changes in chemoattractant receptor expression and integrin signaling presumably promote a switch from
a nonmotile and highly adherent to a highly motile and less adherent state. This change in behavior reduces the time preB cells
spend in contact with IL-7+ cells in the BM, thereby attenuating
Fistonich et al.
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IL-7R signaling. Indeed, IL-7R signaling could be significantly
increased in preB cells by simply overexpressing FAK or a desensitization mutant CXCR4 (R334X), which reduced RAG2 protein
half-life and inhibited both preB cell and subsequent B cell developmental stages by more than threefold. Given that proB cells
do not undergo uncontrolled cell growth in Rag-deficient mice,
other negative feedback mechanisms independent of preBCR signaling likely operate to ensure cell circuit stability.
A surprising observation from our studies was the finding
that IL-7 production is downregulated by signals provided by
preB cells bearing unrepaired DSBs. It is possible that normal
preB cells undergoing transient DSB responses also downregulate IL-7 production and that Artemis deficiency allows
DSBs to persist long enough for changes in IL-7 expression to
be detected. Nevertheless, these observations revealed an unsuspected layer of regulation of preB/IL-7+ cell circuits that
may have evolved to prevent the survival and proliferation of
preleukemic preB cells. However, the fact that BCR-ABL+ preBALLs could also induce IL-7 (and CXCL12) downregulation suggests that leukemic cells exploit certain cell circuit pathways
to reduce the production of nonleukemic B-lineage cells. This
would suggest that normal and leukemic preB cells compete
for similar factors, with nutrients fueling anabolic metabolism
being likely candidates. Future studies addressing nutrient
requirements of normal and leukemic progenitor B cells will
be of high value.
Journal of Experimental Medicine
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Figure 7. DNA repair deficiency in preB cells and control of IL-7 expression in vivo. (A) Longitudinal 30-µm-thick femur section of lethally irradiated
Il7GFP/+ Cxcl12dsRed/+ mice reconstituted with Rag1−/− VH147Igh Eμ-Bcl2 (top panels) or Dclrec1−/− VH147Igh Eμ-Bcl2 BM stained to detect GFP (green), CD19
(cyan), and cell nuclei (DAPI, not shown). Cxcl12-dsRed fluorescent protein (red) was directly visualized. Scale bar, 50 µm. Images are representative of three
individual mice. (B) Quantification of Artemis-deficient (blue) and -sufficient (red) preB cells in contact with IL-7– and CXCL12-producing cells. Bars indicate
mean; circles depict individual mice (n = 3). (C) CXCR4 expression in Artemis-deficient (blue) and -sufficient (red) preB cells in vivo. Numbers indicate geometric
mean fluorescence intensity (GMFI) ± SD (n = 3). (D) Il7-GFP expression in nonhematopoietic Lepr+ BM cells of lethally irradiated Il7GFP/+ mice reconstituted
with Rag1−/− VH147Igh Eμ-Bcl2 or Dclrec1−/− VH147Igh Eμ-Bcl2 BM cells. (E) Quantification of Il7-GFP expression from D. (F) Geometric mean fluorescence
intensity of Il7-GFP expression in nonhematopoietic Lepr+ BM cells of Il7GFP/+ mice 2 wk after transfer of 105 BCR-ABL transduced preB cells. (G) Quantification
of Il7-GFP expression from F. (H) Geometric mean fluorescence intensity of Cxcl12-dsRed expression in nonhematopoietic Lepr+ BM cells of Cxcl12dsred/+ Il7GFP/+
mice 2 wk after transfer of 105 BCR-ABL preB cells. (I) Quantification of Cxcl12-dsRed expression from H. Lines indicate mean; circles depict individual mice
analyzed (n = 3). (J) Terminal deoxynucleotidyl transferase (Tdt) expression in nonleukemic proB cells isolated from mice described in H. (K) Quantification of
terminal deoxynucleotidyl transferase expression from J. (L and M) Total CD19+ host B lymphocytes (L) and granulocytes (M) 2 wk after transfer of 105 BCR-ABL
transduced preB cells. (E, G, and K–M) Lines indicate mean; circles depict individual mice analyzed (n = 3). (N) Model of damaged preB or preB-ALL cell/IL-7+
cell circuit. Data in all panels are representative of two to four independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Materials and methods

Mice
C57BL/6 (CD45.2), Boy/J (CD45.1), and Il7raF/F mice were obtained from the Jackson Laboratory. Il7raF/F mice were crossed
to Mb1cre/+ mice (Pelanda et al., 2002). Rag1GFP/+ mice (Kuwata et
al., 1999) were crossed to each other to generate Rag1GFP/GFP mice.
Rag1−/−, IghB1-8/+, and Rag2:GFP mice were kindly provided by Dr.
David Schatz (Yale University, New Haven, CT). Dclrec1−/−:uIgH:
BCL2 and Rag1−/−:uIgH:BCL2 mice were kindly provided by Dr.
Jeffrey Bednarski (Washington University in St. Louis, St. Louis,
MO). Cxcl12DsRed/+ and Il7GFP/+ mice were from our internal colony. A detailed list of all mouse strains and other materials and
reagents used is provided (Table 1). Mice were maintained under
specific pathogen–free conditions and used according to protocols approved by the Yale University Institutional Animal Care
and Use Committee.
BM chimeras
Il7GFP/+Cxcl12DsRed/+ mice were lethally irradiated with two doses
of 550 rads separated by 3 h and reconstituted with 3 × 106 whole
BM cells of either Rag1−/−, Rag1−/− IghB1-8/+, Rag1GFP/GFP, Rag1GFP/GFP
Igh3-83/+, Dclrec1−/−:VH147Igh:BCL2, or Rag1−/−:VH147Igh:BCL2.
Chimeric mice were analyzed 4 wk after reconstitution. Boy/J
mice were lethally irradiated in the same way and reconstituted
with CXCR4R334X or EV-transduced RAG2:GFP BM.
Tissue preparation, cell enumeration, and flow cytometry
BM cells were flushed from both femurs and tibias in DMEM
containing 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM L-glutamine, and 10 mM Hepes. Spleens were mashed
through 70-µm strainers containing 5 ml of the same media. Cells
were counted with a Beckman Coulter Counter.
Fistonich et al.
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Flow cytometry analyses and cell gating were performed as
previously described (Nevius et al., 2015; Cordeiro Gomes et al.,
2016). Briefly, proB cells were gated as CD19+IgM−CD93+cKit+,
preB cells as CD19+IgM−IgD−CD93+cKit−, immature IgD− as
CD19+IgM+IgD−CD93+, immature IgDlo as CD19+IgM+IgDloCD93+,
and Mat.B as CD19+IgM+IgDhiCD93−. Dead cell dyes (DAPI) were
used for all freshly stained (nonpermeabilized) samples.
Two-photon intravital imaging
Mice were anesthetized with a mixture of ketamine and xylazine before immobilization on a custom-made stereotactic apparatus. Laser-scanning microscopy images were collected using
an Olympus BX61 fluorescence microscope with a 20× 0.95 NA
water-immersion objective and dedicated single-beam TriM
Scope II (LaVision BioTec). The image acquisition software used
was Imspector. Stacks of 18–21 optical sections of 3-µm z-spacing were acquired every 30 s for 30 min. The laser was tuned to
a wavelength of 880 nm. Videos with excessive levels of tissue
drifting were excluded from analysis.
Retroviral transductions of hematopoietic stem and
progenitor cells and BCR-ABL preB-ALLs
The R334X CXCR4 cytoplasmic tail mutant plasmid generation
has been described (Beck et al., 2014). pMXs-puro-EGFP-FAK
was acquired from Addgene (plasmid #38194). Donor Rag2:GFP
or C57BL/6 mice were injected intraperitoneally with 300 µl of
10-mg/ml 5-fluorouracil (5-FU). 5 d after 5-FU injection, BM was
harvested and spin infected with harvested retrovirus for 2 h at
2,450 rpm at room temperature. Recipient mice were then reconstituted with the transduced BM for 4 wk before analysis.
BCR-ABL+ preB-ALL adoptive transfer
BCR-ABL cells were prepared as previously described (Schjerven
et al., 2017). For imaging experiments, 105 BCR-ABL cells transduced with a retroviral vector containing GFP alone or Ptk2IRES-GFP were adoptively transferred into Cxcl12dsRed/+ mice via
intravenous tail vein injection. 14 d later, BM calvaria were imaged
by two-photon intravital microscopy (IVM). For Il7-GFP evaluation experiments (Fig. 7), 105 BCR-ABL cells transduced with a
retroviral vector containing GFP were adoptively transferred
into Il7GFP/+ mice via intravenous tail vein injection and compared
with mock injection. 14 d later, mice were euthanized and BM
IL-7+ mesenchymal cells were analyzed by flow cytometry.
In vivo IL-7R antibody blockade
Mice were intravenously injected with PBS or 200 µg antibody
(clone A7R34). In all cases, treatments lasted for 36 h before
mice were analyzed.
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The fact that DSB-damaged preB cells and normal preB cells
express similar amounts of CXCR4 and are similarly distributed in the BM suggests that DSB-damaged and normal B cell
progenitors interact with the same niche. It remains unclear
if the presence of a single DSB-damaged preB cell is sufficient
for downregulating IL-7 expression in individual IL-7+ cells that
harbor nondamaged B cell progenitors, or if a threshold of damaged preB cells is needed. Nevertheless, these observations raise
the interesting possibility that individual IL-7+ cells are regulated independently, and also that individual cells may return
back to expressing normal amounts of IL-7. In this case, individual IL-7+ cells would be expected to act as single niche units
of lymphopoiesis.
In conclusion, our findings provide support for a novel conceptual model of B cell development where cell circuits between
proB, preB, and IL-7+ cells are wired to control the number and
developmental progression of B cell progenitors, while being
equipped with negative feedback loops that may disfavor the
survival of preleukemic cells. Our findings also suggest that
BCR-ABL+ preB-ALLs exploit IL-7 downregulation to favor leukemic cell growth at the expense of nonleukemic B cells. It will
be important to unravel the molecular and cellular mechanism(s)
controlling IL-7 production in BM niches.

Transwell migration and adhesion assay
Chemotaxis assays were performed with 106 BM cells or 2.5 ×
105 BCR-ABL cells. Cells were incubated for 30 min in RPMI containing 0.5% fatty acid–free BSA, 1% penicillin/streptomycin, 1%
L-glutamine, and 1% Hepes. Cells were then deposited onto the
top of a transwell containing 5-µm pores and allowed to migrate
for 3 h toward varying concentrations of CXCL12 in the bottom
chamber at 37°C. Cells were then harvested, stained, and resusJournal of Experimental Medicine
https://doi.org/10.1084/jem.20180778
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Table 1. List of reagents, DNA constructs and mouse strains, sources, and catalog numbers
Reagent or resource

Source

Identifier

APC BrdU Flow Kit

BD Biosciences

Cat#557892

Donkey polyclonal anti-goat biotin

Jackson ImmunoResearch

Cat#705-065-003

Antibodies

Donkey polyclonal anti-rabbit Alexa488

Life Technologies

Cat#A21206

Donkey polyclonal anti-rat Alexa488

Jackson ImmunoResearch

Cat#112-545-003

Jackson ImmunoResearch

Cat#112-065-003

BD Biosciences

Cat#559619

Goat polyclonal anti-GFP

Rockland

Cat#600-101-215

Mouse monoclonal anti-human CD4 biotin

BD Biosciences

Clone RPA-T4; Cat#555345

Mouse monoclonal anti-human CD4 PE

BD Biosciences

Clone L200; Cat#550630

Mouse monoclonal anti-mouse FAK

Invitrogen

Clone ZF002; Cat#39-6500

Rat monoclonal anti-CXCR4 biotin

eBioscience

Clone 2B11; Cat#13-9991-82

Rat monoclonal anti-mouse CD19 BV711

BioLegend

Clone 6D5; Cat#115555

Rat monoclonal anti-mouse CD19 PE

BioLegend

Clone 6D5; Cat#115508

Rat monoclonal anti-mouse CD93 APC

BioLegend

Clone AA4.1; Cat#136510

Rat monoclonal anti-mouse cKIT BV421

BioLegend

Clone ACK2; Cat#135124

Rat monoclonal anti-mouse cKIT BV711

BioLegend

Clone 2B8; Cat#105835

Rat monoclonal anti-mouse IgD BV711

BioLegend

Clone 11-26c.2A; Cat#405731

Rat monoclonal anti-mouse IgD PE

BioLegend

Clone 11-26c.2A; Cat#405706

Rat monoclonal anti-mouse IgG1 PE

BD Biosciences

Clone A85-1; Cat#550083

Rat monoclonal anti-mouse IgM PECy7

eBioscience

Clone II/41; Cat#25-5790-81

Rat monoclonal anti-mouse Ikaros PE

BioLegend

Clone 2A9; Cat#653304

Rat monoclonal anti-mouse Integrin α4 PE

Southern Biotech

Clone PS/2; Cat#1520-09L

Rat monoclonal anti-mouse pSTAT5 (Y694) BV421

BD Biosciences

Clone 47/Stat5; Cat#562077

Streptavidin Alexa700

Life Technologies

Cat#S21383

Streptavidin BV605

BioLegend

Cat#405229

Streptavidin BV711

BioLegend

Cat#405241

Invitrogen

Cat#18265017

Bacterial and virus strains
“Subcloning efficiency” DH5α competent cells (F− Φ80lacZΔM15
Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk−, mk+) phoA supE44
thi-1 gyrA96 relA1 λ−)
Biological samples
N/A
Chemicals, peptides, and recombinant proteins
DMSO

American Bioanalytical

CAS:67-68-5

Ibrutinib (PCI-32765)

Selleck Chemicals

Cat#S2680

Fostamatinib (R788)

Selleck Chemicals

Cat#S2625

Critical commercial assays
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Donkey polyclonal anti-rat biotin
FITC BrdU Flow Kit

N/A
Deposited data
N/A
Experimental models: Cell lines
HEK293T
BCR-ABL

Fistonich et al.
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Gift from Dr. David Schatz, Yale
University
Schjerven et al., 2017

Gift from Dr. Hilde Schjerven, University
of California, San Francisco
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Table 1. List of reagents, DNA constructs and mouse strains, sources, and catalog numbers (Continued)
Reagent or resource

Source

Identifier

Mus musculus, strain Mb1cre

Pelanda et al., 2002

Gift from J.G. Cyster, University of
California, San Francisco

Mus musculus, strain Il7rtm1.1Asin/J (Il7rFlox)

McCaughtry et al., 2012

The Jackson Laboratory, Cat#022143

Mus musculus, strain RAG2:GFP

Monroe et al., 1999

Gift from Dr. David Schatz, Yale
University

Mus musculus, strain Rag1−/−

Mombaerts et al., 1992

Gift from Dr. David Schatz, Yale
University

Experimental models: Organisms/strains

Kuwata et al., 1999

Our internal colony

Mus musculus, strain IghB1-8 (B6.129P2(C)-Ightm2Cgn/J)

Sonoda et al., 1997

Gift from Dr. David Schatz, Yale
University

Mus musculus, strain Igh3-83 (C.129P2(B6)-Igktm1Rsky Ightm2Rsky/PldJ)

Pelanda et al., 1997

The Jackson Laboratory, Cat#011074

Mus musculus, strain Il7GFP

Miller et al., 2013

Gift from Dr. Susan Kaech, Yale
University

Mus musculus, strain Cxcl12DsRed

Ding and Morrison, 2013

Gift from Dr. Sean Morrison, University
of Texas Southwestern Medical Center

Mus musculus, strain C57BL/6J

The Jackson Laboratory

Stock no. #000664

Hara et al., 2008

Addgene plasmid #38194

Oligonucleotides
N/A
Recombinant DNA
pMXs-puro-EGFP-FAK
pMSCV

CXCR4R334X

IRES GFP

Pereira laboratory

N/A

pMSCV

CXCR4R334X

IRES hCD4

This paper

N/A

FlowJo version 9.6.4

Tree Star

http://www.flowjo.com
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pended in 40 µl of staining buffer before analysis for 40 s by flow
cytometry. For adhesion assays, transwells were precoated with 1,
3, or 10 µg/ml mouse VCAM-1 at 4°C overnight before performing
the assay as otherwise described.
In vitro stimulations and inhibitions
Approximately 106 whole BM cells were cultured in IMDM containing 20% FBS, 1% penicillin/streptomycin, 1% L-glutamine,
1% Hepes, and 50 µM β-mercaptoethanol. For all stimulations,
anti-CD79b (clone HM79b) was given to cells at a concentration
of 10 µg/ml for 8 h. Stimulations were confirmed by observing
IgM internalization of mature B lymphocytes by flow cytometry.
For inhibitions, cells were given a combination of fostamatinib
(1 µM) and ibrutinib (1 µM) or wortmannin (1 µM) for 6 h and
were compared with vehicle (DMSO) control.
BM immunofluorescence microscopy
The distinction of proB and preB cells based on the intensity of
RAG2:GFP expression was determined as follows: a histogram
distribution of voxels for RAG2:GFP in individual CD19+ cells was
generated from individual images captured from longitudinal
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femur sections (z = 30 µm). The top 10% of CD19+ cells with the
highest GFP expression (voxels) was classified as proB (GFPHi),
and the remaining cells were classified as preB (GFPLo). In Fig. 1,
D, E, and G, and Fig. 7 B, each circle represents the average frequency of proB or preB cells in contact with CXCL12+ cells obtained in one mouse. The average frequency was calculated from
>200–300 proB and preB cells analyzed from 10 images obtained
from longitudinal femur sections imaged by confocal microscopy.
Femurs and tibias were fixed in 4% paraformaldehyde in
PBS for 5 h followed by washing with PBS three times. Bones
were submerged in 30% sucrose overnight before being snap
frozen in optimal cutting temperature media (Tissue-Tek) in
a bath of hexane surrounded by dry ice. Bone was shaved off
using a cryostat (Leica) until the surface of BM was visible. The
bone was then placed in a bath of room temperature PBS to melt
remaining optimum cutting temperature compound, followed
by permeabilization in 0.1% Triton X-100 for 2 h. Bones were
stained with primary antibodies for 3 d at 4°C, followed by secondary antibodies for 1 d at 4°C and tertiary antibodies for 1 d at
4°C. Images were acquired on a Leica SP8 confocal microscope
using a 20× oil-immersion objective (0.75 NA). For random posiJournal of Experimental Medicine
https://doi.org/10.1084/jem.20180778
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tioning analysis, spots placed on DAPI+ and CD19− cells in Imaris
software were given a random identifier in Microsoft Excel
using the RANDBETWEEN() function, and randomly assigned
spots were analyzed.

Statistics
Student’s two-tailed t test or χ2 tests were performed using
PRISM 6 (Graphpad Software) or Excel (Microsoft). P values
<0.05 were considered significant.
Online supplemental material
Video 1 shows proB and preB cell movement within calvaria BM
of live mice. Video 2 shows proB cell movement in calvaria BM of
live mice treated with PBS or with 200 µg of anti–IL-7Ra antibody
(clone A7R34). Video 3 shows the in vivo behavior of BCR-ABL+
preB cells retrovirally transduced to overexpress FAK or EV.
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